OVOL3: A Potential Drug Target and Biomarker for Stroke and Cognitive Impairment

Target Name: OVOL3

NCBI ID: G728361

OVOL3

OVOL3: A Potential Drug Target and Biomarker for Stroke and Cognitive Impairment

Stroke is a leading cause of death worldwide, resulting in significant morbidity and economic burden. The neurodegenerative disorder, Alzheimer's disease, is the most common cause of dementia, affecting millions of people worldwide. Cognitive impairment, including memory, language, and problem-solving skills, is a common complication in both stroke and Alzheimer's disease. OVOL3, a putative transcription factor ovo-like protein 3, has been identified as a potential drug target and biomarker for stroke and cognitive impairment.

OVOL3 is a 21-kDa protein that is expressed in various tissues, including brain, heart, and liver. It is involved in the regulation of cell proliferation, differentiation, and survival. The protein has been shown to play a role in the development and progression of both stroke and Alzheimer's disease.

Studies have suggested that OVOL3 may be involved in the pathogenesis of both stroke and cognitive impairment. For example, OVOL3 has been shown to be highly expressed in the brains of individuals with Alzheimer's disease, and it has been implicated in the development of neurofibrillary tangles and senile plaques, which are hallmark hallmarks of Alzheimer's disease. In addition, OVOL3 has been shown to be involved in the regulation of the blood-brain barrier, which is a critical barrier that protects the brain from harmful substances and therapies.

OVOL3 has also been shown to be involved in the regulation of ion channels, which are critical for the flow of electrical signals in the brain. The disruption of ion channels has been implicated in the pathogenesis of both stroke and cognitive impairment. OVOL3 has been shown to play a role in the regulation of Na+ and K+ channels, which are critical for the maintenance of the resting membrane potential of neurons.

In addition to its role in the regulation of ion channels, OVOL3 has also been shown to play a role in the regulation of gene expression. Studies have shown that OVOL3 can interact with various transcription factors, including AP-1, to regulate the expression of target genes. This interaction between OVOL3 and transcription factors suggests that OVOL3 may be a potential drug target for the treatment of stroke and cognitive impairment.

The potential drug targets for OVOL3 are numerous. For example, OVOL3 has been shown to play a role in the regulation of cell proliferation and survival, which are critical for the development of both stroke and cognitive impairment. In addition, OVOL3 has been shown to play a role in the regulation of the blood-brain barrier, which is a critical barrier that protects the brain from harmful substances and therapies.

OVOL3 has also been shown to play a role in the regulation of ion channels, which are critical for the flow of electrical signals in the brain. The disruption of ion channels has been implicated in the pathogenesis of both stroke and cognitive impairment. OVOL3 has been shown to play a role in the regulation of Na+ and K+ channels, which are critical for the maintenance of the resting membrane potential of neurons.

In addition to its role in the regulation of ion channels, OVOL3 has also been shown to play a role in the regulation of gene expression. Studies have shown that OVOL3 can interact with various transcription factors, including AP-1, to regulate the expression of target genes. This interaction between OVOL3 and transcription factors suggests that OVOL3 may be a potential drug target for the treatment of stroke and cognitive impairment.

In conclusion, OVOL3 is a putative transcription factor ovo-like protein 3 that has been shown to play a role in the development and progression of both stroke and Alzheimer's disease. The potential drug targets for OVOL3 are numerous, including the regulation of cell

Protein Name: Ovo Like Zinc Finger 3

Functions: May act as a transcription regulator

The "OVOL3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OVOL3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets